Covered recipient · General Payments record
KELLY A TANASE
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2022–2023
$1,328.92
- Reported across 59 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $825.60 | 41 |
| Education | $189.95 | 2 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $242.75 | 5 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $98.29 | 5 |
| Gilead Sciences, Inc. | $60.02 | 3 |
| Regeneron Healthcare Solutions, Inc. | $49.99 | 2 |
| Genentech USA, Inc. | $43.58 | 2 |
| Incyte Corporation | $38.77 | 2 |
| Janssen Biotech, Inc. | $36.78 | 2 |
| JAZZ PHARMACEUTICALS INC. | $35.39 | 1 |
| Amgen Inc. | $32.58 | 2 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $29.92 | 1 |
| Pharmacosmos Therapeutics Inc. | $28.64 | 1 |
| Merck Sharp & Dohme Corporation | $27.14 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $25.20 | 1 |
| SEAGEN INC. | $24.46 | 1 |
| ARRAY BIOPHARMA INC | $21.49 | 1 |
| EISAI INC. | $19.60 | 1 |
| Spectrum Pharmaceuticals Inc. | $19.16 | 1 |
| Acerta Pharma LLC | $19.15 | 1 |
| Foundation Medicine, Inc. | $18.85 | 1 |
| Blueprint Medicines Corporation | $18.70 | 1 |
| G1 Therapeutics, Inc. | $18.41 | 1 |
| Genmab U.S., Inc. | $17.62 | 1 |
| MorphoSys, US Inc. | $16.82 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $16.74 | 1 |
| Blue Earth Diagnostics | $14.59 | 1 |
| Celgene Corporation | $13.76 | 1 |
| PFIZER INC. | $13.58 | 1 |
| Acrotech Biopharma Inc. | $13.57 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (43)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2022, 2023
- Source files
- Dataset page · Bulk file · PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.